Free Trial
OTCMKTS:PORBF

Pola Orbis (PORBF) Stock Price, News & Analysis

Pola Orbis logo
$8.70 0.00 (0.00%)
As of 05/12/2026

About Pola Orbis Stock (OTCMKTS:PORBF)

Advanced

Key Stats

Today's Range
$8.70
$8.70
50-Day Range
$8.70
$8.70
52-Week Range
$8.70
$9.30
Volume
N/A
Average Volume
N/A
Market Capitalization
$1.92 billion
P/E Ratio
28.06
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PORBF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pola Orbis and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PORBF Stock News Headlines

Pola Orbis Outlines Q1 FY2026 Performance and Strategy
Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform tied to Conor McGregor and Dana White - reaching millions of combat sports and biohacking followers worldwide. On April 15, RFK Jr. announced the FDA would remove 12 peptides from restricted Category 2 status. This company was already selling products tied to three of those peptides - and has developed a patent-pending transdermal patch addressing the 63.2% of adults with needle phobia. The peptide therapeutics market is projected to reach $294 billion by 2033.tc pixel
See More Headlines

PORBF Stock Analysis - Frequently Asked Questions

Pola Orbis' stock was trading at $9.10 at the beginning of 2026. Since then, PORBF stock has decreased by 4.4% and is now trading at $8.70.

Pola Orbis (OTCMKTS:PORBF) announced its quarterly earnings data on Friday, February, 13th. The company reported $0.13 earnings per share for the quarter, beating the consensus estimate of $0.06 by $0.07. The business had revenue of $288.95 million for the quarter, compared to analyst estimates of $291.93 million. Pola Orbis had a net margin of 6.30% and a trailing twelve-month return on equity of 9.86%.

Shares of PORBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
2/13/2026
Today
5/14/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
COSMETICS&TLTRS
Sub-Industry
N/A
Current Symbol
OTCMKTS:PORBF
Previous Symbol
NASDAQ:PORBF
CIK
N/A
Fax
N/A
Employees
4,046
Year Founded
2006

Profitability

EPS (Trailing Twelve Months)
$0.28
Trailing P/E Ratio
28.06
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$63.46 million
Net Margins
6.30%
Pretax Margin
7.81%
Return on Equity
9.86%
Return on Assets
8.20%

Debt

Debt-to-Equity Ratio
0.01
Current Ratio
4.00
Quick Ratio
3.37

Sales & Book Value

Annual Sales
$1.14 billion
Price / Sales
1.69
Cash Flow
$0.65 per share
Price / Cash Flow
13.46
Book Value
$4.94 per share
Price / Book
1.76

Miscellaneous

Outstanding Shares
221,260,000
Free Float
N/A
Market Cap
$1.92 billion
Optionable
Not Optionable
Beta
0.16

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report

This page (OTCMKTS:PORBF) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners